Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Quantum Biopharma (QNTM) Return on Capital Employed (2024 - 2025)

Quantum Biopharma's Return on Capital Employed history spans 2 years, with the latest figure at 231.9% for Q4 2025.

  • On a quarterly basis, Return on Capital Employed fell 12670.0% to 231.9% in Q4 2025 year-over-year; TTM through Dec 2025 was 231.9%, a 12670.0% decrease, with the full-year FY2025 number at 189.34%, down 3737.0% from a year prior.
  • Return on Capital Employed hit 231.9% in Q4 2025 for Quantum Biopharma, down from 185.93% in the prior quarter.
  • Over the last five years, Return on Capital Employed for QNTM hit a ceiling of 105.2% in Q4 2024 and a floor of 791.35% in Q2 2025.